Joseph Hernandez - 07 Jun 2022 Form 4 Insider Report for Clarus Therapeutics Holdings, Inc.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 07 Jun 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 09 Jun 2022, 20:02:36 UTC
Prior SEC filing: 27 May 2022
Next SEC filing: 22 Aug 2022
Source filing: View source filing
Reporting owner signature: /s/ Steven A. Bourne, attorney-in-fact

Key filing fact

Joseph Hernandez filed Form 4 for Clarus Therapeutics Holdings, Inc. on 09 Jun 2022.

Key facts

This page summarizes Joseph Hernandez's Form 4 filing for Clarus Therapeutics Holdings, Inc..
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 09 Jun 2022, 20:02.

Change

Previous filing in this sequence was filed on 27 May 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRXT transaction

Common Stock

Award

Transaction value: $0
Shares: +1,922
Change %: +0.15%
Price: $0.000000
Shares after: 1,243,266
Date: 07 Jun 2022
Ownership: Direct
Footnotes: F1

CRXT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 65,000
Date: 07 Jun 2022
Ownership: See Footnote
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CRXT transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +4,805
Change %
Price: $0.000000
Shares after: 4,805
Date: 07 Jun 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,805
Exercise price: $0.4339
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The Reporting Person was granted a Restricted Stock Unit under the Issuer's 2021 Stock Option and Incentive Plan (the "2021 Plan") for 1,922 shares on 06/07/2022, which vests in full at the earlier of June 7, 2023 or the next annual meeting subject to the Reporting Person having a service relationship as of each such vesting.

Footnote F2

These options were granted under the 2021 Plan and vest in full at the earlier of June 7, 2023 or the next annual meeting subject to the Reporting Person having a service relationship as of each such vesting.

Footnote F3

These shares are held by Blue Water Sponsor LLC (the "Sponsor"). Mr. Joseph Hernandez, a director and former chief executive officer of the registrant, is the managing member of the Sponsor. Accordingly, Mr. Hernandez may be deemed to have beneficial ownership of such shares. Mr. Hernandez disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly.